Amarin (AMRN) Stock: Buy, Sell, or Hold?
AMRN - Amarin Corp Plc
$11.60
0.09 (0.78%)
▲
5d:
+0.26%
30d:
-15.45%
90d:
-14.39%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When AMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AMRN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: AMRN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: AMRN is currently trading at $11.60, which is considered oversold relative to its 30-day fair value range of $11.66 to $13.53. From a valuation perspective, the stock is trading at a discount (Forward PE: -193.3) compared to its historical average (17.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, AMRN is in a strong downtrend. Immediate support is located at $11.25, while resistance sits at $12.20.
Market Sentiment: AMRN scores 78/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AMRN is in a strong downtrend. Immediate support is located at $11.25, while resistance sits at $12.20.
Market Sentiment: AMRN scores 78/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.66 -
$13.53
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (78/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($12.50)
- BULLISH: Bottoming setup score 78/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$11.66 -
$13.53
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$11.25
Resistance Level
$12.20
Current Trend
Strong Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-193.33
Wall Street Target
$12.50
(+7.8%)
Revenue Growth (YoY)
-42.0%
Earnings Growth (YoY)
-94.2%
Profit Margin
-14.6%
PE vs Historical
-193.3 vs 17.3
CHEAP
Share & Embed Analysis
Last updated: October 22, 2026 6:05 PM ET
Data refreshes hourly during market hours. Next update: 7:05 PM
Data refreshes hourly during market hours. Next update: 7:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ABBV
AbbVie Inc |
STRONG BUY
30 analysts |
$283 | 44 HOLD |
|
GILD
Gilead Sciences Inc |
STRONG BUY
28 analysts |
$160 | 43 HOLD |
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1328 | 27 SELL |
|
BIIB
Biogen Inc |
BUY
36 analysts |
$244 | 39 SELL |
|
MRK
Merck & Company Inc |
STRONG BUY
27 analysts |
$158 | 43 HOLD |
